Literature DB >> 7268920

How environmental mycobacteria may predetermine the protective efficacy of BCG.

J L Stanford, M J Shield, G A Rook.   

Abstract

A proposal is made that there are 2 mechanisms of cell mediated response to mycobacteria, both of which produce positive tuberculin tests and that one of them is more protective against mycobacterial infection than is the other. These are referred to respectively as the Listeria-type and the Koch-type of responses. Contact with environmental mycobacteria will induce one or other of these types of response and BCG vaccination will enhance it. Thus in those places where the environmental species prime for the Listeria-type of response subsequent BCG vaccination will afford good protection from both tuberculosis and leprosy. Where the Koch-type of response frequently results from environmental contact BCG will be ineffective. Evidence if presented that a large contact with Mycobacterium scrofulaceum is prejudicial to at least one marker of BCG efficacy in Burma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7268920     DOI: 10.1016/0041-3879(81)90037-4

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  28 in total

Review 1.  Effective vaccination against tuberculosis-a new ray of hope.

Authors:  J M Grange
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Measurements of blood flow and histometry of the cellular infiltrate in tuberculin skin test responses of the typical Koch type and the non-turgid variant form (Listeria-type) in pulmonary tuberculosis patients and apparently healthy controls.

Authors:  R C Potts; J S Beck; J H Gibbs; J M Grange; T Kardjito; J L Stanford
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

3.  Optimization of procedures for isolation of mycobacteria from soil and water samples obtained in northern India.

Authors:  Deepti Parashar; D S Chauhan; V D Sharma; Aradhana Chauhan; S V S Chauhan; V M Katoch
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

4.  Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production.

Authors:  A S Mustafa; G Kvalheim; M Degre; T Godal
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

5.  Isolation and Identification of Environmental Mycobacteria in the Mycobacterium bovis BCG Trial Area of South India.

Authors:  T Kamala; C N Paramasivan; D Herbert; P Venkatesan; R Prabhakar
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

6.  Sensitivity of neonates to tuberculin after BCG vaccination.

Authors:  A J Lyon
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

7.  Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle.

Authors:  J C Hope; M L Thom; B Villarreal-Ramos; H M Vordermeier; R G Hewinson; C J Howard
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

8.  BCG-induced suppressor T cells optimal conditions for in vitro induction and mode of action.

Authors:  A S Mustafa; T Godal
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

9.  Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

Authors:  B M Buddle; D N Wedlock; N A Parlane; L A L Corner; G W De Lisle; M A Skinner
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.